Hansoh Pharmaceutical Group Co (HKSE:03692) Long-Term Capital Lease Obligation : HK$71 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Long-Term Capital Lease Obligation?

Hansoh Pharmaceutical Group Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$71 Mil.

Hansoh Pharmaceutical Group Co's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$89 Mil) to Jun. 2023 (HK$81 Mil) and declined from Jun. 2023 (HK$81 Mil) to Dec. 2023 (HK$71 Mil).

Hansoh Pharmaceutical Group Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$92 Mil) to Dec. 2022 (HK$89 Mil) and declined from Dec. 2022 (HK$89 Mil) to Dec. 2023 (HK$71 Mil).

Hansoh Pharmaceutical Group Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Long-Term Capital Lease Obligation Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

6.44

96.86

91.73

88.86

70.78

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial									91.73	101.04	88.86	81.04	70.78

Hansoh Pharmaceutical Group Co (HKSE:03692) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Hansoh Pharmaceutical Group Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines